Advertisement

Celltrion

Share

Celltrion prices Omlyclo 15% below Xolair in US launch Korea Biomedical Review 02:31 Tue, 06 Oct

Korea Biomedical Review 02:31 Tue, 06 Oct

Celltrion deepens bet on US biotech Kaigene with 3rd autoimmune drug candidate Korea Biomedical Review 1d

Korea Biomedical Review 1d

Biotechnology Pharma

Celltrion expands Avtozma's US label to Covid-19 patients aged 2 and older Korea Biomedical Review 08:37 Wed, 07 Oct

Korea Biomedical Review 08:37 Wed, 07 Oct

Advertisement

Advertisement

Celltrion secures three autoimmune drug candidates through deal with U.S. firm Kaigene Asia Today 1d

Asia Today 1d

Biotechnology Pharma

Celltrion nears additional contract with major U.S. Pbm Asia Today 05:20 Wed, 14 Oct

Asia Today 05:20 Wed, 14 Oct

Celltrion launches omalizumab biosimilar in the United States JD Supra 23:54 Wed, 14 Oct

JD Supra 23:54 Wed, 14 Oct

Advertisement

Advertisement

Latest

In the last 4 hours

Celltrion and Kaigene sign $580m licence deal for KG013 Hospital Management 10:44

Yesterday

Kaigene Enters into Exclusive Global Licensing Agreement with Celltrion for Next-Generation Anti-April Antibody KG013 PR Newswire (Press Release) 14:02 Thu, 22 Oct

Celltrion secures three autoimmune drug candidates through deal with U.S. firm Kaigene Asia Today 07:20 Thu, 22 Oct

Celltrion deepens bet on US biotech Kaigene with 3rd autoimmune drug candidate Korea Biomedical Review 05:38 Thu, 22 Oct

In the last month

Celltrion to highlight Remsima SC clinical data at UEG Week 2026 The Korea Herald 03:28 Thu, 15 Oct

Celltrion to present real-world Remsima SC data at UEG Week 2026 Korea Biomedical Review 02:35 Thu, 15 Oct

Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at Ueg Week 2026 Business Wire (Press Release) 01:16 Thu, 15 Oct

Celltrion Launches Omalizumab Biosimilar in the United States JD Supra 23:54 Wed, 14 Oct

Celltrion nears additional contract with major U.S. PBM Asia Today 05:20 Wed, 14 Oct

Spotlight On: Herceptin® (trastuzumab) / Ogivri® (trastuzumab-dkst) / Herzuma® (trastuzumab-pkrb) / Ontruzant® (trastuzumab-dttb)... JD Supra 17:33 Tue, 13 Oct

Advertisement

Advertisement

Advertisement

Advertisement

About our Celltrion news

Latest news on Celltrion, a biopharmaceutical company headquartered in Incheon, South Korea.